Thiazolidinediones (TZDs) are PPARγ agonists, currently used for the treatment of insulin resistance and type 2 diabetes mellitus [8], while fibrates are mainly PPARα agonists that are efficient in lowering elevated triglyceride concentrations [9]. Here, PPARG is linked to diabetes mellitus.